The impact of the new acute respiratory distress syndrome (ARDS) criteria on Berlin criteria ARDS patients: a multicenter cohort study.
ARDS criteria
Acute respiratory distress syndrome
Multicenter cohort study
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
23 Nov 2023
23 Nov 2023
Historique:
received:
22
08
2023
accepted:
31
10
2023
medline:
27
11
2023
pubmed:
24
11
2023
entrez:
23
11
2023
Statut:
epublish
Résumé
The European Society of Intensive Care Medicine (ESICM) recently recommended changes to the criteria of acute respiratory distress syndrome (ARDS), patients with high-flow oxygen were included, however, the effect of these changes remains unclear. Our objectives were to evaluate the performance of these new criteria and to compare the outcomes of patients meeting the new ARDS criteria with those meeting the Berlin ARDS criteria. This was a retrospective cohort. The patients admitted to the intensive care unit (ICU) were diagnosed with ARDS. Patients were classified as meeting Berlin criteria ARDS (n = 4279), high-flow nasal oxygen (HFNO) criteria ARDS (n = 559), or new criteria ARDS (n = 4838). In comparison with HFNO criteria ARDS and new criteria ARDS, patients with Berlin criteria ARDS demonstrated lower blood oxygen levels assessed by PaO The new criteria of ARDS reduced the severity of illness, length of stay in the ICU, length of hospital stays, and overall mortality. SOFA and APACHE II scores remain important in assessing the prognosis of patients with new criteria ARDS. Registration number: ChiCTR2200067084.
Identifiants
pubmed: 37996902
doi: 10.1186/s12916-023-03144-7
pii: 10.1186/s12916-023-03144-7
pmc: PMC10666384
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
456Subventions
Organisme : Natural Science Foundation of Inner Mongolia
ID : 2022MS08002
Organisme : Tianjin Municipal Health Commission
ID : TJWJ2023QN007
Organisme : National Natural Science Foundation of China
ID : 82302413
Informations de copyright
© 2023. The Author(s).
Références
JAMA. 2021 Dec 07;326(21):2161-2171
pubmed: 34874419
JAMA. 2017 Jan 17;317(3):290-300
pubmed: 28114553
Crit Care. 2019 May 23;23(1):186
pubmed: 31122276
Lancet. 1967 Aug 12;2(7511):319-23
pubmed: 4143721
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Intensive Care Med. 2023 Jul;49(7):727-759
pubmed: 37326646
Crit Care. 2017 Apr 4;21(1):85
pubmed: 28376908
Lancet Respir Med. 2020 Dec;8(12):1209-1218
pubmed: 32861275
Chest. 2016 Aug;150(2):307-13
pubmed: 26836924
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
JAMA. 2022 Feb 8;327(6):546-558
pubmed: 35072713
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Crit Care Med. 2017 Aug;45(8):1317-1324
pubmed: 28538439
Crit Care. 2015 Mar 11;19:82
pubmed: 25887535
N Engl J Med. 2018 Aug 30;379(9):884-887
pubmed: 30157406
Intensive Care Med. 2015 Feb;41(2):231-8
pubmed: 25510299
Sci Data. 2023 Jan 3;10(1):1
pubmed: 36596836
Intensive Care Med. 2020 Dec;46(12):2238-2247
pubmed: 32901374
Sci Data. 2018 Sep 11;5:180178
pubmed: 30204154
Intensive Care Med. 2000 Dec;26(12):1773-8
pubmed: 11271084
Intensive Care Med. 2021 Jan;47(1):60-73
pubmed: 33211135
Crit Care. 2016 Nov 29;20(1):384
pubmed: 27894328
Crit Care. 2021 Jan 8;25(1):22
pubmed: 33419456